This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerppola, T K
Right arrow Articles by Curran, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerppola, T K
Right arrow Articles by Curran, T

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 June; 13(6): 3782-3791

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

T K Kerppola, D Luk and T Curran

Department of Molecular Oncology and Virology, Roche Institute of Molecular Biology, Nutley, New Jersey 07110.

ABSTRACT

Several regulatory interactions between the AP-1 and the nuclear hormone receptor families of transcription factors have been reported. However, the molecular mechanisms that underlie these interactions remain unknown, and models derived from transient-transfection experiments are contradictory. We have investigated the effect of the purified glucocorticoid receptor (GR) DNA-binding domain (GR residues 440 to 533 [GR440-533]) on DNA binding and transcription activation by Fos-Jun heterodimers and Jun homodimers. GR440-533 differentially inhibited DNA binding and transcription activation by Fos-Jun heterodimers. Inhibition of Jun homodimers required a 10-fold-higher concentration of GR440-533. An excess of Fos monomers protected Fos-Jun heterodimers from inhibition by GR440-533. Surprisingly, regions outside the leucine zipper and basic region were required for GR inhibition of Fos and Jun DNA binding. The region of GR440-533 required for inhibition of Fos-Jun DNA binding was localized to the zinc finger DNA-binding domain. However, inhibition of Fos-Jun DNA binding was independent of DNA binding by GR440-533. GR440-533 also differentially inhibited Fos-Jun heterodimer binding to the proliferin plfG element. Differential inhibition of DNA binding by different AP-1 family complexes provides a potential mechanism for the diverse interactions between nuclear hormone receptors and AP-1 family proteins at different promoters and in different cell types.


Mol Cell Biol. 1993 June; 13(6): 3782-3791




This article has been cited by other articles:

  • Diefenbacher, M., Sekula, S., Heilbock, C., Maier, J. V., Litfin, M., van Dam, H., Castellazzi, M., Herrlich, P., Kassel, O. (2008). Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1. Mol. Endocrinol. 22: 1767-1780 [Abstract] [Full Text]  
  • Kang, B. N., Jude, J. A., Panettieri, R. A. Jr., Walseth, T. F., Kannan, M. S. (2008). Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L186-L193 [Abstract] [Full Text]  
  • Kang, B.-N., Tirumurugaan, K. G., Deshpande, D. A., Amrani, Y., Panettieri, R. A., Walseth, T. F., Kannan, M. S. (2006). Transcriptional regulation of CD38 expression by tumor necrosis factor-{alpha} in human airway smooth muscle cells: role of NF-{kappa}B and sensitivity to glucocorticoids. FASEB J. 20: 1000-1002 [Abstract] [Full Text]  
  • Wu, J., Iwata, F., Grass, J. A., Osborne, C. S., Elnitski, L., Fraser, P., Ohneda, O., Yamamoto, M., Bresnick, E. H. (2005). Molecular Determinants of NOTCH4 Transcription in Vascular Endothelium. Mol. Cell. Biol. 25: 1458-1474 [Abstract] [Full Text]  
  • Wu, W., Pew, T., Zou, M., Pang, D., Conzen, S. D. (2005). Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival. J. Biol. Chem. 280: 4117-4124 [Abstract] [Full Text]  
  • Jiang, X., Norman, M., Roth, L., Li, X. (2004). Protein-DNA Array-based Identification of Transcription Factor Activities Regulated by Interaction with the Glucocorticoid Receptor. J. Biol. Chem. 279: 38480-38485 [Abstract] [Full Text]  
  • Mittelstadt, P. R., Ashwell, J. D. (2003). Disruption of Glucocorticoid Receptor Exon 2 Yields a Ligand-Responsive C-Terminal Fragment that Regulates Gene Expression. Mol. Endocrinol. 17: 1534-1542 [Abstract] [Full Text]  
  • Terzic, N., Vujcic, M., Ristic-Fira, A., Krstic-Demonacos, M., Milanovic, D., Kanazir, D. T., Ruzdijic, S. (2003). Effects of Age and Dexamethasone Treatment on Glucocorticoid Response Element and Activating Protein-1 Binding Activity in Rat Brain. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58: B297-303 [Abstract] [Full Text]  
  • Almawi, W. Y., Melemedjian, O. K. (2002). Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J. Leukoc. Biol. 71: 9-15 [Abstract] [Full Text]  
  • Morin, B., Woodcock, G. R., Nichols, L. A., Holland, L. J. (2001). Heterodimerization between the Glucocorticoid Receptor and the Unrelated DNA-Binding Protein, Xenopus Glucocorticoid Receptor Accessory Factor. Mol. Endocrinol. 15: 458-466 [Abstract] [Full Text]  
  • Chen, R., Burke, T. F., Cumberland, J. E., Brummet, M., Beck, L. A., Casolaro, V., Georas, S. N. (2000). Glucocorticoids Inhibit Calcium- and Calcineurin-Dependent Activation of the Human IL-4 Promoter. J. Immunol. 164: 825-832 [Abstract] [Full Text]  
  • Fujiki, M., Shinbori, T., Suga, M., Miyakawa, H., Ando, M. (1999). Role of T Cells in Bronchoalveolar Space in the Development of Interstitial Pneumonia Induced by Superantigen in Autoimmune-Prone Mice. Am. J. Respir. Cell Mol. Bio. 21: 675-683 [Abstract] [Full Text]  
  • Prefontaine, G. G., Walther, R., Giffin, W., Lemieux, M. E., Pope, L., Hache, R. J. G. (1999). Selective Binding of Steroid Hormone Receptors to Octamer Transcription Factors Determines Transcriptional Synergism at the Mouse Mammary Tumor Virus Promoter. J. Biol. Chem. 274: 26713-26719 [Abstract] [Full Text]  
  • McKay, L. I., Cidlowski, J. A. (1999). Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways. Endocr. Rev. 20: 435-459 [Abstract] [Full Text]  
  • Lukiw, W. J., Martinez, J., Pelaez, R. P., Bazan, N. G. (1999). The Interleukin-1 Type 2 Receptor Gene Displays Immediate Early Gene Responsiveness in Glucocorticoid-stimulated Human Epidermal Keratinocytes. J. Biol. Chem. 274: 8630-8638 [Abstract] [Full Text]  
  • He, H., Qi, X.-M., Grossmann, J., Distelhorst, C. W. (1998). c-Fos Degradation by the Proteasome. AN EARLY, Bcl-2-REGULATED STEP IN APOPTOSIS. J. Biol. Chem. 273: 25015-25019 [Abstract] [Full Text]  
  • Wei, P., Inamdar, N., Vedeckis, W. V. (1998). Transrepression of c-jun Gene Expression by the Glucocorticoid Receptor Requires Both AP-1 Sites in the c-jun Promoter. Mol. Endocrinol. 12: 1322-1333 [Abstract] [Full Text]  
  • van Dam, H., Huguier, S., Kooistra, K., Baguet, J., Vial, E., van der Eb, A. J., Herrlich, P., Angel, P., Castellazzi, M. (1998). Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev. 12: 1227-1239 [Abstract] [Full Text]  
  • Lukiw, W. J., Pelaez, R. P., Martinez, J., Bazan, N. G. (1998). Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta -induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. Proc. Natl. Acad. Sci. USA 95: 3914-3919 [Abstract] [Full Text]  
  • Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., Resche-Rigon, M. (1997). Synthetic Glucocorticoids That Dissociate Transactivation and AP-1 Transrepression Exhibit Antiinflammatory Activity in Vivo. Mol. Endocrinol. 11: 1245-1255 [Abstract] [Full Text]  
  • Cui, H., Matsui, K., Omura, S., Schauer, S. L., Matulka, R. A., Sonenshein, G. E., Ju, S.-T. (1997). Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 94: 7515-7520 [Abstract] [Full Text]  
  • Powers, C., Krutzsch, H., Gardner, K. (1996). Modulation of JunD·AP-1 DNA Binding Activity by AP-1-associated Factor 1(AF-1). J. Biol. Chem. 271: 30089-30095 [Abstract] [Full Text]  
  • Kim-Schulze, S., McGowan, K. A., Hubchak, S. C., Cid, M. C., Martin, M. B., Kleinman, H. K., Greene, G. L., Schnaper, H. W. (1996). Expression of an Estrogen Receptor by Human Coronary Artery and Umbilical Vein Endothelial Cells. Circulation 94: 1402-1407 [Abstract] [Full Text]  
  • Ozer, J., Bolden, A. H., Lieberman, P. M. (1996). Transcription Factor IIA Mutations Show Activator-specific Defects and Reveal a IIA Function Distinct from Stimulation of TBP-DNA Binding. J. Biol. Chem. 271: 11182-11190 [Abstract] [Full Text]  
  • Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., Baldwin, A. S. Jr. (1995). Role of Transcriptional Activation of IkappaBalpha in Mediation of Immunosuppression by Glucocorticoi ds. Science 270: 283-286 [Abstract]  
  • Porte, D., Oertel-Buchheit, P., Granger-Schnarr, M.èl. (1995). Fos Leucine Zipper Variants with Increased Association Capacity. J. Biol. Chem. 270: 22721-22730 [Abstract] [Full Text]  
  • Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M. J., Young, H. A. (1995). Negative Transcriptional Regulation of the Interferon-[IMAGE] Promoter by Glucocorticoids and Dominant Negative Mutants of c-Jun. J. Biol. Chem. 270: 12548-12556 [Abstract] [Full Text]  
  • Ozer, J, Moore, P A, Bolden, A H, Lee, A, Rosen, C A, Lieberman, P M (1994). Molecular cloning of the small (gamma) subunit of human TFIIA reveals functions critical for activated transcription.. Genes Dev. 8: 2324-2335 [Abstract]  
  • Barres, B., Lazar, M., Raff, M. (1994). A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120: 1097-1108 [Abstract]  
  • McCaffrey, P., Luo, C, Kerppola, T., Jain, J, Badalian, T., Ho, A., Burgeon, E, Lane, W., Lambert, J., Curran, T, et, al. (1993). Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750-754 [Abstract]